AMERICAN CENTURY COMPANIES INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$9,210,739
+21.8%
200,277
+52.2%
0.01%
+16.7%
Q2 2023$7,563,569
+66.2%
131,609
+8.9%
0.01%
+50.0%
Q1 2023$4,551,327
+318.6%
120,821
+211.4%
0.00%
+300.0%
Q4 2022$1,087,176
-30.9%
38,800
-30.7%
0.00%0.0%
Q3 2022$1,573,000
-0.2%
55,980
+23.6%
0.00%0.0%
Q2 2022$1,576,000
-43.9%
45,293
-42.1%
0.00%
-50.0%
Q1 2022$2,808,000
+28.9%
78,230
-16.3%
0.00%
+100.0%
Q4 2021$2,178,000
+36.0%
93,512
+11.0%
0.00%0.0%
Q3 2021$1,601,000
-14.9%
84,221
-9.7%
0.00%0.0%
Q2 2021$1,881,000
+302.8%
93,288
+222.0%
0.00%0.0%
Q2 2016$467,00028,9670.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders